Gresonitamab
Gresonitamab (AMG 910) is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody targets CD3-positive T cells and CLDN18.2-expressing tumor cells. Gresonitamab can be used for the research of adenocarcinoma[1].
Product Specifications
CAS Number
2413817-97-5
Product Name Alternative
AMG 910; Anti-Human CD3xClaudin18 2
UNSPSC
12352203
Target
CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gresonitamab.html
Purity
99.44
Solubility
10 mM in DMSO
Smiles
[Gresonitamab]
Molecular Weight
(106 kDa)
References & Citations
[1]Cao W, et al. Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy. Biomark Res. 2022 May 31;10 (1) :38.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P03794-carrier-free 100 µL
Anti-Phospho-Synapsin I (S9) Rabbit Monoclonal Antibody, Carrier-free
Sign In for Pricing
View Details C2255-01G-ML650 100 µL
CD4 (CD4 Receptor, CD4mut, T Cell Surface Antigen T4/Leu3, T Cell Surface Glycoprotein CD4 (MaxLight 650) discontinued
Sign In for Pricing
View Details